Muhammad Shahab
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Muhammad Shahab has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Fazal Wahab
Department of Endocrinology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China
7 shared publicationsRahim Ullah
Laboratory of Reproductive Neuroendocrinology, Department of Zoology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan
6 shared publicationsF. Wahab
Department of Physiology, Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan
5 shared publicationsHira Zubair
Department of Zoology , Quaid-i-Azam University , Islamabad , 45320 , Pakistan , qau.edu.pk
4 shared publications- Ghulam Nabi
School of Food and Biological Engineering Jiangsu University Zhenjiang China
3 shared publications Hamid Ullah
Laboratory of Reproductive Neuroendocrinology, Department of Zoology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Andrologia
- Vol. 2026 (1) , 8848418
Modulation of Diet‐Induced Vitamin D Deficiency on Reproductive Hormones Secretion and Gene Expression in Adult Male Rats
Vitamin D deficiency is increasingly being recognized as a health concern, especially due to its role in male infertility. The present research was designed to systematically investigate the effects of dietary vitamin D on hormone secretion and gene expression at three levels of the male reproductive axis. Adult male rats ( n = 60) were housed in hygienic and well‐ventilated conditions in stainless steel cages at optimum temperature in an animal housing facility with 12 h light/dark cycle and were randomly divided into three equal groups. The control group was fed on a standard rodent diet. The vitamin D deficient (VDD) group was fed a VDD diet, and the third group (VDCP) was maintained on a VDD diet, but the feed was supplemented with calcium and phosphate. After 60 days of feeding, blood samples were obtained for hormone assays, and the animals were sacrificed. Hypothalamic, pituitary glands, and testicular tissues were obtained for real‐time polymerase chain reaction (RT‐PCR). The hypothalamic GnRH content was significantly decreased ( p < 0.05) in VDD and VDCP groups. FSH and LH levels were significantly decreased ( p < 0.05) in the VDD group. In the VDD group, RT‐PCR showed significant downregulation ( p < 0.05) of GnRH, FSH, and LH mRNA expression. The inhibin B was significantly reduced in both VDD and VDCP groups ( p < 0.05). VDD diet affected the reproductive hormones release and mRNA expression of GnRH in the hypothalamus, FSH, LH in the pituitary, and inhibin B in testicular tissues showing modulating effects on synthesis/release of these hormones.
- 1 January 2026
- Published by Wiley in Andrologia
- Vol. 2026 (1) , 8848418
Open AccessModulation of Diet‐Induced Vitamin D Deficiency on Reproductive Hormones Secretion and Gene Expression in Adult Male Rats
Vitamin D deficiency is increasingly being recognized as a health concern, especially due to its role in male infertility. The present research was designed to systematically investigate the effects of dietary vitamin D on hormone secretion and gene expression at three levels of the male reproductive axis. Adult male rats ( n = 60) were housed in hygienic and well‐ventilated conditions in stainless steel cages at optimum temperature in an animal housing facility with 12 h light/dark cycle and were randomly divided into three equal groups. The control group was fed on a standard rodent diet. The vitamin D deficient (VDD) group was fed a VDD diet, and the third group (VDCP) was maintained on a VDD diet, but the feed was supplemented with calcium and phosphate. After 60 days of feeding, blood samples were obtained for hormone assays, and the animals were sacrificed. Hypothalamic, pituitary glands, and testicular tissues were obtained for real‐time polymerase chain reaction (RT‐PCR). The hypothalamic GnRH content was significantly decreased ( p < 0.05) in VDD and VDCP groups. FSH and LH levels were significantly decreased ( p < 0.05) in the VDD group. In the VDD group, RT‐PCR showed significant downregulation ( p < 0.05) of GnRH, FSH, and LH mRNA expression. The inhibin B was significantly reduced in both VDD and VDCP groups ( p < 0.05). VDD diet affected the reproductive hormones release and mRNA expression of GnRH in the hypothalamus, FSH, LH in the pituitary, and inhibin B in testicular tissues showing modulating effects on synthesis/release of these hormones.
- Open Access
Variation in Hypothalamic GnIH Expression and Its Association with GnRH and Kiss1 during Pubertal Progression in Male Rhesus Monkeys (Macaca mulatta)
Modulation of pulsatile gonadotropin-releasing hormone (GnRH) secretion across postnatal development in higher primates is not fully understood. While gonadotropin-inhibitory hormone (GnIH) is reported to suppress reproductive axis activity in birds and rodents, little is known about the developmental trajectory of GnIH expression in rhesus monkeys throughout the pubertal transition. This study was aimed at examining the variation in GnIH immunoreactivity (-ir) and associated changes among GnIH, GnRH, and Kiss1 mRNA expression in the hypothalamus of infant, juvenile, prepubertal, and adult male rhesus monkeys. The brains from rhesus macaques were collected from infancy until adulthood and were examined using immunofluorescence and RT-qPCR. The mean GnIH-ir was found to be significantly higher in prepubertal animals (p < 0.01) compared to infants, and significantly reduced in adults (p < 0.001). Significantly higher (p < 0.001) GnRH and Kiss1 mRNA expression was noted in adults while GnIH mRNA expression was the highest at the prepubertal stage (p < 0.001). Significant negative correlations were seen between GnIH-GnRH (p < 0.01) and GnIH-Kiss1 (p < 0.001) expression. Our findings suggest a role for GnIH in the prepubertal suppression of the reproductive axis, with disinhibition of the adult reproductive axis occurring through decreases in GnIH. This pattern of expression suggests that GnIH may be a viable target for the development of novel therapeutics and contraceptives for humans.
Open AccessVariation in Hypothalamic GnIH Expression and Its Association with GnRH and Kiss1 during Pubertal Progression in Male Rhesus Monkeys (Macaca mulatta)
Modulation of pulsatile gonadotropin-releasing hormone (GnRH) secretion across postnatal development in higher primates is not fully understood. While gonadotropin-inhibitory hormone (GnIH) is reported to suppress reproductive axis activity in birds and rodents, little is known about the developmental trajectory of GnIH expression in rhesus monkeys throughout the pubertal transition. This study was aimed at examining the variation in GnIH immunoreactivity (-ir) and associated changes among GnIH, GnRH, and Kiss1 mRNA expression in the hypothalamus of infant, juvenile, prepubertal, and adult male rhesus monkeys. The brains from rhesus macaques were collected from infancy until adulthood and were examined using immunofluorescence and RT-qPCR. The mean GnIH-ir was found to be significantly higher in prepubertal animals (p < 0.01) compared to infants, and significantly reduced in adults (p < 0.001). Significantly higher (p < 0.001) GnRH and Kiss1 mRNA expression was noted in adults while GnIH mRNA expression was the highest at the prepubertal stage (p < 0.001). Significant negative correlations were seen between GnIH-GnRH (p < 0.01) and GnIH-Kiss1 (p < 0.001) expression. Our findings suggest a role for GnIH in the prepubertal suppression of the reproductive axis, with disinhibition of the adult reproductive axis occurring through decreases in GnIH. This pattern of expression suggests that GnIH may be a viable target for the development of novel therapeutics and contraceptives for humans.
- 22 July 2022
- Published by Taylor & Francis in Endocrine Research
- Vol. 47 (3-4) , 113-123
Morphometric and Myelin Basic Protein Expression Changes in Arcuate Nucleus Kisspeptin Neurons Underlie Activation of Hypothalamic Pituitary Gonadal-axis in Monkeys (Macaca Mulatta) during the Breeding Season
Kisspeptin is involved in the hypothalamic pituitary gonadal-axis’ seasonal regulation in rodents and sheep. Studies of kisspeptin signaling in regulating the transition between breeding and nonbre...
- 22 July 2022
- Published by Taylor & Francis in Endocrine Research
- Vol. 47 (3-4) , 113-123
Morphometric and Myelin Basic Protein Expression Changes in Arcuate Nucleus Kisspeptin Neurons Underlie Activation of Hypothalamic Pituitary Gonadal-axis in Monkeys (Macaca Mulatta) during the Breeding Season
Kisspeptin is involved in the hypothalamic pituitary gonadal-axis’ seasonal regulation in rodents and sheep. Studies of kisspeptin signaling in regulating the transition between breeding and nonbre...
- 7 April 2022
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 18 (7) , 392
Triggering puberty in primates: is it NPY?
- 7 April 2022
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 18 (7) , 392
Triggering puberty in primates: is it NPY?
- 13 January 2022
- Published by Elsevier in Reproductive Biology
- Vol. 22 (1) , 100599
Inverse age-related changes between hypothalamic NPY and KISS1 gene expression during pubertal initiation in male rhesus monkey
- 13 January 2022
- Published by Elsevier in Reproductive Biology
- Vol. 22 (1) , 100599
Inverse age-related changes between hypothalamic NPY and KISS1 gene expression during pubertal initiation in male rhesus monkey
- Open Access
- 25 February 2021
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 12
RF9 Rescues Cortisol-Induced Repression of Testosterone Levels in Adult Male Macaques
Cortisol inhibits hypothalamic-pituitary-gonadal (HPG) axis whereas RF9, a potent agonist of kisspeptin receptor (GPR54) activates HPG-axis during fasting-induced stress and under normal physiological conditions. However, the effect of RF9 on the cortisol-induced repressed HPG-axis is not studied yet. This study investigated whether exogenous cortisol-induced repression of the HPG-axis can be rescued by RF9. Six intact adult male rhesus monkeys (Macaca mulatta) habituated to chair-restraint were administered hydrocortisone sodium succinate at a rate of 20 mg/kg of body weight (BW) per day for 12 days. Single blood sample was taken by venipuncture from each animal on alternate days for hormones analyses. On experimental day 12, hydrocortisone treated monkeys received a single intravenous bolus of RF9 (n = 3) and vehicle (n = 3). The animals were bled for a period of 4 h at 60 min intervals from an indwelling cannula in the saphenous vein. RF9 was administered intravenously at the dose of 0.1 mg/kg BW immediately after taking 0 min sample. Plasma cortisol and testosterone concentrations were measured by using specific enzyme immunoassays. Hydrocortisone treatment increased plasma cortisol levels (P ≤ 0.0001) and decreased plasma testosterone (P ≤ 0.0127) levels. Interestingly, compared to vehicle, RF9 treatment significantly increased plasma testosterone levels at 120 min (P ≤ 0.0037), 180 min (P ≤ 0.0016), and 240 min (P ≤ 0.0001) intervals in the hydrocortisone treated monkeys. From these results, we concluded that RF9 administration relieves the suppressed HPG-axis in term of plasma testosterone levels in the cortisol treated monkeys.
- 25 February 2021
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 12
Open AccessRF9 Rescues Cortisol-Induced Repression of Testosterone Levels in Adult Male Macaques
Cortisol inhibits hypothalamic-pituitary-gonadal (HPG) axis whereas RF9, a potent agonist of kisspeptin receptor (GPR54) activates HPG-axis during fasting-induced stress and under normal physiological conditions. However, the effect of RF9 on the cortisol-induced repressed HPG-axis is not studied yet. This study investigated whether exogenous cortisol-induced repression of the HPG-axis can be rescued by RF9. Six intact adult male rhesus monkeys (Macaca mulatta) habituated to chair-restraint were administered hydrocortisone sodium succinate at a rate of 20 mg/kg of body weight (BW) per day for 12 days. Single blood sample was taken by venipuncture from each animal on alternate days for hormones analyses. On experimental day 12, hydrocortisone treated monkeys received a single intravenous bolus of RF9 (n = 3) and vehicle (n = 3). The animals were bled for a period of 4 h at 60 min intervals from an indwelling cannula in the saphenous vein. RF9 was administered intravenously at the dose of 0.1 mg/kg BW immediately after taking 0 min sample. Plasma cortisol and testosterone concentrations were measured by using specific enzyme immunoassays. Hydrocortisone treatment increased plasma cortisol levels (P ≤ 0.0001) and decreased plasma testosterone (P ≤ 0.0127) levels. Interestingly, compared to vehicle, RF9 treatment significantly increased plasma testosterone levels at 120 min (P ≤ 0.0037), 180 min (P ≤ 0.0016), and 240 min (P ≤ 0.0001) intervals in the hydrocortisone treated monkeys. From these results, we concluded that RF9 administration relieves the suppressed HPG-axis in term of plasma testosterone levels in the cortisol treated monkeys.
- Open Access
- 10 September 2020
- Published by Springer Nature in Cureus
- Vol. 12 (9)
Erythropoietin Administration for Anemia Due to Chronic Kidney Disease - Subcutaneous OR Intravenous, What Do We Know So Far?
The prevalence of anemia in chronic kidney disease (CKD) patients is almost twice that of the normal population and its severity increases exponentially as the disease worsens, dramatically affecting the quality of an individual’s life. The advent of erythropoiesis stimulating agents (ESA) in the 1980s saw a revolutionary change in the treatment of anemia in CKD patients, drastically improving quality of life (QoL), overall health and reducing the need for blood transfusions. Numerous ESAs have been developed ever since and are in current use, with the primary routes of administration being intravenous (IV) and subcutaneous (SC) injections. Their use, however, has stirred significant controversy over the last two decades. Additionally, despite numerous studies and trials, the latest international recommendations for their use do not provide clear cut guidance with well-grounded evidence on the recommended route of administration for different sets of patients. Instead, this decision has mainly been left up to the physician’s discretion, whilst keeping certain key factors in mind. This review shall summarize, discuss and compare the findings of previous studies on various factors governing the two aforementioned routes of administration and identify areas that need further exploration.
- 10 September 2020
- Published by Springer Nature in Cureus
- Vol. 12 (9)
Open AccessErythropoietin Administration for Anemia Due to Chronic Kidney Disease - Subcutaneous OR Intravenous, What Do We Know So Far?
The prevalence of anemia in chronic kidney disease (CKD) patients is almost twice that of the normal population and its severity increases exponentially as the disease worsens, dramatically affecting the quality of an individual’s life. The advent of erythropoiesis stimulating agents (ESA) in the 1980s saw a revolutionary change in the treatment of anemia in CKD patients, drastically improving quality of life (QoL), overall health and reducing the need for blood transfusions. Numerous ESAs have been developed ever since and are in current use, with the primary routes of administration being intravenous (IV) and subcutaneous (SC) injections. Their use, however, has stirred significant controversy over the last two decades. Additionally, despite numerous studies and trials, the latest international recommendations for their use do not provide clear cut guidance with well-grounded evidence on the recommended route of administration for different sets of patients. Instead, this decision has mainly been left up to the physician’s discretion, whilst keeping certain key factors in mind. This review shall summarize, discuss and compare the findings of previous studies on various factors governing the two aforementioned routes of administration and identify areas that need further exploration.
- 27 December 2018
- Published by Wiley in Andrologia
- Vol. 51 (4) , e13219
Age‐dependent changes in the reproductive axis responsiveness to kisspeptin‐10 administration in healthy men
The present study was designed to assess the responsiveness of hypothalamic–pituitary–gonadal axis to kisspeptin administration with increasing age in men. Human kisspeptin‐10 was administered in single iv bolus dose (1 µg/kg BW) to healthy adult, middle and advanced age men. Serial blood samples were collected for 30 min pre‐ and 120 min post‐kisspeptin injection periods at 30‐min interval. Analysis of plasma LH by ELISA showed a significant (p < 0.05) increase after kisspeptin‐10 administration in all groups, whereas plasma testosterone concentration was significantly elevated (p < 0.05) after kisspeptin‐10 injection only in the adult men group. Present results suggest that in men, central hypothalamic–pituitary axis remains active and shows responsiveness to kisspeptin stimulation across life. However, Leydig cell responsiveness to kisspeptin‐induced LH decreases with age in men.
- 27 December 2018
- Published by Wiley in Andrologia
- Vol. 51 (4) , e13219
Age‐dependent changes in the reproductive axis responsiveness to kisspeptin‐10 administration in healthy men
The present study was designed to assess the responsiveness of hypothalamic–pituitary–gonadal axis to kisspeptin administration with increasing age in men. Human kisspeptin‐10 was administered in single iv bolus dose (1 µg/kg BW) to healthy adult, middle and advanced age men. Serial blood samples were collected for 30 min pre‐ and 120 min post‐kisspeptin injection periods at 30‐min interval. Analysis of plasma LH by ELISA showed a significant (p < 0.05) increase after kisspeptin‐10 administration in all groups, whereas plasma testosterone concentration was significantly elevated (p < 0.05) after kisspeptin‐10 injection only in the adult men group. Present results suggest that in men, central hypothalamic–pituitary axis remains active and shows responsiveness to kisspeptin stimulation across life. However, Leydig cell responsiveness to kisspeptin‐induced LH decreases with age in men.
- Top Cited PapersOpen Access
- 15 September 2018
- Published by MDPI AG in Brain Sciences
- Vol. 8 (9) , 177
Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
Regeneration refers to regrowth of tissue in the central nervous system. It includes generation of new neurons, glia, myelin, and synapses, as well as the regaining of essential functions: sensory, motor, emotional and cognitive abilities. Unfortunately, regeneration within the nervous system is very slow compared to other body systems. This relative slowness is attributed to increased vulnerability to irreversible cellular insults and the loss of function due to the very long lifespan of neurons, the stretch of cells and cytoplasm over several dozens of inches throughout the body, insufficiency of the tissue-level waste removal system, and minimal neural cell proliferation/self-renewal capacity. In this context, the current review summarized the most common features of major neurodegenerative disorders; their causes and consequences and proposed novel therapeutic approaches.
- 15 September 2018
- Published by MDPI AG in Brain Sciences
- Vol. 8 (9) , 177
Top Cited PapersOpen AccessNeurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
Regeneration refers to regrowth of tissue in the central nervous system. It includes generation of new neurons, glia, myelin, and synapses, as well as the regaining of essential functions: sensory, motor, emotional and cognitive abilities. Unfortunately, regeneration within the nervous system is very slow compared to other body systems. This relative slowness is attributed to increased vulnerability to irreversible cellular insults and the loss of function due to the very long lifespan of neurons, the stretch of cells and cytoplasm over several dozens of inches throughout the body, insufficiency of the tissue-level waste removal system, and minimal neural cell proliferation/self-renewal capacity. In this context, the current review summarized the most common features of major neurodegenerative disorders; their causes and consequences and proposed novel therapeutic approaches.